Auris Medical (EARS) Shows Strength: Stock Rises 22.4%

Zacks

Auris Medical Holding AG EARS was a big mover last session, as its shares rose over 22% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. Yesterday’s rally breaks the recent trend for the company, as the stock is now trading above the volatile price range of $3.02 to $3.73 in the past one-month time frame.

Over the last 30 days, the company witnessed one positive estimate revision and the Zacks Consensus Estimate also moved higher, suggesting more solid trading ahead. So make sure to keep an eye on this stock going forward to see if yesterday’s jump can turn into more strength down the road.

Auris Medical currently has a Zacks Rank #2 (Buy) while its Earnings ESP is negative.

Another favorably ranked med-drugs stock is Corcept Therapeutics CORT with a Zacks Rank #1 (Strong Buy).

Is EARS going up? Or down? Predict to see what others think: Up or Down

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

To read this article on Zacks.com click here.

Zacks Investment Research

Be the first to comment

Leave a Reply